US9023317B2ExpiredUtilityPatentIndex 47
Polymer precursors of radiolabeled compounds, and methods of making and using the same
Est. expiryMar 2, 2021(expired)· nominal 20-yr term from priority
A61K 51/06C07D 211/14C08F 8/32C07D 207/06C07K 1/042C07D 295/13C07B 59/00C07C 231/14C07B 2200/11C08F 8/42C07B 59/002C07K 1/13C07B 59/001
47
PatentIndex Score
0
Cited by
27
References
2
Claims
Abstract
One aspect of the present invention relates to novel compounds that can be used to prepare radiolabeled compounds in an effective manner. A second aspect of the present invention relates to a method of synthesizing radiolabeled compounds.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method of synthesizing a radiolabeled benzamide on a solid support comprising:
a) selecting a solid support comprising at least one compound attached to said solid support, wherein the compound is selected from the group consisting of:
Poly-(4S,5S)-2-(5-{dibutyl[2-(4-vinylphenyl)ethyl]stannyl}-2,3-dihydrobenzofuran-7-yl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine-co-divinylbenzene;
Poly-(4S,5S)-2-(4-{dibutyl[2-(3-vinylphenyl)ethyl]stannyl}phenyl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine-co-divinylbenzene; and
Poly-(4S,5S)-2-(4-{dibutyl[2-(4-vinylphenyl)ethyl]stannyl}phenyl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine-co-divinylbenzene;
b) reacting said compound with at least one acid to afford a benzoic acid moiety or a carboxylic acid moiety;
c) reacting said moiety of said compound attached to said solid support with at least one amine to afford a benzamide bound to a solid support; and
d) reacting said benzamide bound to said solid support with a radioisotope; and an oxidant selected from the group consisting of chloramine-T,N-chlorosuccinimide, tert-butylhydroperoxide, iodogen, iodobeads and meta-chloroperbenzoic acid; to yield said radiolabeled benzamide.
2. The method of claim 1 wherein the radioisotope is selected from the group consisting of 18 F, 11 C, 76 Br, 123 I, 131 I and 125 I.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.